Yet do much less ... so much less!

被引：0
作者：
Lipton, Jeffrey H. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
BLOOD | 2019年 / 134卷 / 01期
关键词：
CHRONIC MYELOID-LEUKEMIA; MONITORING PATTERNS;
D O I：
10.1182/blood.2019001014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Shanmuganathan et al have presented a model that has redefined the frequency of molecular (polymerase chain reaction [PCR] for BCR-ABL) testing in patients discontinuing tyrosine kinase therapy for chronic myeloid leukemia (CML) as part of attempts at treatment-free remission (TFR). This is a less conservative, more feasible approach that should make safe discontinuation a reality for more patients.(1)
引用
收藏
页码：6 / 7
页数：4
相关论文
共 5 条
  • [1] Response: Too much BCR-ABL to live on, but too little BCR-ABL to die on?
    Burchert, Andreas
    Neubauer, Andreas
    Hochhaus, Andreas
    BLOOD, 2012, 119 (12) : 2965 - 2966
  • [2] T315I, more or less, predicts for major molecular response: the devil is in the details!
    Mauro, Michael J.
    HAEMATOLOGICA, 2013, 98 (05) : 665 - 666
  • [3] Successful Treatment with Imatinib Combined with Less Intensive Chemotherapy (Vincristine and Dexamethasone) as Induction Therapy in a Very Elderly Patient with Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia
    Kazuhiro Nishii
    Miho Sakakura
    Tetsuya Tsukada
    Hyou Ryuu
    Naoyuki Katayama
    International Journal of Hematology, 2007, 85 : 273 - 274
  • [4] Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome
    Ohm, Lotta
    Arvidsson, Ingrid
    Barbany, Gisela
    Hast, Robert
    Stenke, Leif
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (08) : 760 - 765
  • [5] Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia
    Shimoni, A.
    Leiba, M.
    Schleuning, M.
    Martineau, G.
    Renaud, M.
    Koren-Michowitz, M.
    Ribakovski, E.
    le Coutre, P.
    Arnold, R.
    Guilhot, F.
    Nagler, A.
    LEUKEMIA, 2009, 23 (01) : 190 - 194
1